Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit (agrément Crédit Impôt Recherche) by the French Ministry of Higher (...)
Position: Post Doc (PhD) in Organic Synthesis / Medicinal Chemistry in Montpellier (France) - fix term contract 12 months, starting Feb-March 2017The Post Doc in medicinal chemistry will be responsible for (...)
Oxeltis team will attend Biofit 2016 in Lille – France (29th Nov. – 1st Dec. 2016), and will be happy to meet you to discuss your current and future projects (...)
Oxeltis will be happy to meet you at the International Round Table in Paris, July 18-22, 2016 to discuss your current and future projects involving nucleoside chemistry.Oxeltis is known for– (...)
Oxeltis management team will be happy to meet you in San Francisco to discuss your current and future projects involving medicinal chemistry and custom synthesis.We look forward meeting you soon (...)
Oxeltis is at MEET2WIN, Oncology business convention in Bordeaux May 12-13. Come to discuss your current and future projects involving medicinal chemistry (FTE contracts for Hit selection & optimization, H2L (...)
Oxeltis team would be happy to meet you at the 29th International Conference on Antiviral Research (ICAR 2016, La Jolla (CA-USA), April 17-21, 2016), to discuss your current and future projects involving medicinal (...)
Oxeltis will be present at BIO-Europe Spring (April 4-6th, 2016, Stockholm) We will be happy to meet you to discuss your current and future projects involving- medicinal chemistry (FTE contracts for Hit (...)